Nintedanib plus pemetrexed/cisplatin followed by maintenance nintedanib for unresectable malignant pleural mesothelioma (MPM): An international, multicenter, randomized, double-blind, placebo-controlled phase II study.

Phase Ii Study ◽

Pleural Mesothelioma ◽

Double Blind ◽

Double Blind Placebo ◽

International Multicenter

COMMAND: A phase II randomized, double-blind, placebo-controlled, multicenter study of defactinib as maintenance therapy in subjects with malignant pleural mesothelioma that has not progressed on at least four cycles of pemetrexed/platinum therapy.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps7611 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS7611-TPS7611 ◽

Cited By ~ 1

Author(s):

Dean Anthony Fennell ◽

Paul Baas ◽

Hedy Lee Kindler ◽

Lee M. Krug ◽

Anna Nowak ◽

...

Keyword(s):

Maintenance Therapy ◽

Phase Ii ◽

Multicenter Study ◽

Pleural Mesothelioma ◽

Double Blind ◽

1900P RAMES trial: A multicentre, double-blind, randomized, phase II study on gemcitabine plus ramucirumab versus gemcitabine alone as second-line treatment for advanced malignant pleural mesothelioma (MPM)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1443 ◽

2020 ◽

Vol 31 ◽

pp. S1078

Author(s):

M. Pagano ◽

G.L. Ceresoli ◽

P.A. Zucali ◽

G. Pasello ◽

M.C. Garassino ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Pleural Mesothelioma ◽

Line Treatment ◽

Second Line ◽

Double Blind ◽

Randomized Phase Ii

A Randomized, Double‐Blind , Placebo‐Controlled , Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study

The Oncologist ◽

10.1634/theoncologist.2020-0679 ◽

2020 ◽

Vol 25 (11) ◽

Author(s):

Richard F. Riedel ◽

Karla V. Ballman ◽

Yao Lu ◽

Steven Attia ◽

Elizabeth T. Loggers ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Refractory

Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182333df5 ◽

2011 ◽

Vol 6 (11) ◽

pp. 1950-1954 ◽

Cited By ~ 47

Author(s):

Scott A. Laurie ◽

Ashish Gupta ◽

Quincy Chu ◽

Christopher W. Lee ◽

Wojciech Morzycki ◽

...

Keyword(s):

Clinical Trials ◽

Phase Ii ◽

Phase Ii Study ◽

Pleural Mesothelioma

Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)

Annals of Oncology ◽

10.1093/annonc/mdw370.95 ◽

2016 ◽

Vol 27 ◽

pp. vi180

Author(s):

S. Yuki ◽

Y. Komatsu ◽

H. Satake ◽

Y. Miyamoto ◽

H. Tanioka ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　– A Randomized, Double-Blind, Placebo-Controlled Phase II Study –

Circulation Journal ◽

10.1253/circj.cj-15-1112 ◽

2016 ◽

Vol 80 (3) ◽

pp. 668-676 ◽

Cited By ~ 18

Author(s):

Hiroyuki Tsutsui ◽

Shinichi Momomura ◽

Akira Yamashina ◽

Hisao Ogawa ◽

Hiroaki Shimokawa ◽

...

Keyword(s):

Heart Failure ◽

Heart Rate ◽

Chronic Heart Failure ◽

Phase Ii ◽

Rate Control ◽

Phase Ii Study ◽

Japanese Patients ◽

Heart Rate Control ◽

Double Blind ◽

Efficacy and Safety of Additional 200-mg Dose of Celecoxib in Adult Patients With Postoperative Pain Following Extraction of Impacted Third Mandibular Molar: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Japan

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.01.004 ◽

2012 ◽

Vol 34 (2) ◽

pp. 314-328 ◽

Cited By ~ 10

Author(s):

Ken‘ichi Saito ◽

Akihiro Kaneko ◽

Katsuyuki Machii ◽

Hiroyoshi Ohta ◽

Masayuki Ohkura ◽

...

Keyword(s):

Postoperative Pain ◽

Phase Ii ◽

Phase Ii Study ◽

Adult Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Mandibular Molar

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-1558 ◽

2017 ◽

Vol 24 (2) ◽

pp. 316-325 ◽

Cited By ~ 7

Author(s):

Axel Grothey ◽

Jonathan R. Strosberg ◽

Lindsay A. Renfro ◽

Herbert I. Hurwitz ◽

John L. Marshall ◽

...

Keyword(s):

Colorectal Cancer ◽

Supportive Care ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Best Supportive Care ◽

Efficacy And Safety ◽

Double Blind ◽

Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e318229586e ◽

2011 ◽

Vol 6 (11) ◽

pp. 1938-1945 ◽

Cited By ~ 65

Author(s):

Linda L. Garland ◽

Kari Chansky ◽

Antoinette J. Wozniak ◽

Anne S. Tsao ◽

Shirish M. Gadgeel ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Pleural Mesothelioma

NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(18)30193-1 ◽

2018 ◽

Vol 19 (6) ◽

pp. 799-811 ◽

Cited By ~ 25

Author(s):

Vanesa Gregorc ◽

Rabab M Gaafar ◽

Adolfo Favaretto ◽

Francesco Grossi ◽

Jacek Jassem ◽

...

Keyword(s):

Pleural Mesothelioma ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Previously Treated